WO1997007216A1 - Deuteriated substances - Google Patents
Deuteriated substances Download PDFInfo
- Publication number
- WO1997007216A1 WO1997007216A1 PCT/GB1996/001988 GB9601988W WO9707216A1 WO 1997007216 A1 WO1997007216 A1 WO 1997007216A1 GB 9601988 W GB9601988 W GB 9601988W WO 9707216 A1 WO9707216 A1 WO 9707216A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- deuteriated
- organism
- substance
- series
- eftu
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/36—Adaptation or attenuation of cells
Definitions
- the present invention concerns methods for making substantially deuteriated substances and substances produced according to the method ofthe present invention.
- Deuteriated proteins are normally obtained by growing E. coli bearing a suitable overproducing vector on a fully deuteriated medium.
- the best medium used to date is deuteriated algal hydrolysate, but this is difficult to prepare, expensive and subject to fluctuations in availability (Daboll, H.F., et al, 1962, Biotechnology and Bioengineering, IV: 281).
- the most widely used alternative is based on d 4 -succinate and D 2 0, but this medium is generally characterised by poor yields of protein (e.g. Oda, Y., et al, 1992, J. Biomol. NMR, 2: 137-147).
- the present invention overcomes the disadvantages of the prior art and provides a simple, convenient, efficient, and less expensive method for producing substantially deuteriated substances.
- a method for producing a substantially deuteriated substance comprising the steps of growing on a deuteriated medium an organism producing the substance, wherein the organism has been adapted to deuteriated medium such that on a deuteriated medium it produces approximately the same quantity of the deuteriated substance as the non-adapted organism produces ofthe non-deuteriated substance on a non-deuteriated medium.
- the organism may be unicellular or multicellular.
- the organism may, for example, be a bacterium, a prokaryote, an alga or a fungus.
- the substance may for example be a protein, an antibiotic or nucleic acid.
- the substance may be the bacterial elongation factor Tu (EFTu).
- the substance produced may be at least 85% deuteriated. It may for example be at least 90% or 95% deuteriated.
- the organism may have been adapted by growth in a series of cultures, the first culture containing less deuterium than the final culture.
- the organism may have been grown to an A 550 of approximately 1.0 in each ofthe series of cultures.
- Each culture in the series may contain more deuterium than the preceding culture.
- the cultures may contain d 4 -succinate and D 2 0 as the sources of deuterium.
- the series may be a series of at least three cultures. It may be a series of 3, 4, 5, 6, 7, 8, 9 or 10 cultures.
- the organism may have been adapted by growth in a series of cultures containing d 4 -succinate and D 2 0, each culture ofthe series containing more deuterium than the preceding culture. It may for example have been a series of four cultures containing 70%, 80%, 90% and 100% D 2 0 respectively.
- the organism may also have been further adapted to growth at a raised temperature. It may have been adapted to growth at 42°C.
- 'raised temperature' is meant a raised temperature relative to the normal growth temperature for the organism, in the case of bacteria this being about 37°C.
- the substance may be subsequently harvested.
- the adapted organism may be E. coli or a derivative thereof. It may be derived from E. coli MRE600. It may for example be Bacillus subtilis or streptomyces, e.g. Saccharopolyspora erythraea. Derivatives of a micro-organism may be progeny of the micro-organism in which it has e.g. given up DNA to, or accepted DNA from, another micro-organism, the progeny exhibiting the same, or substantially the same, characteristics.
- the adapted organism may be E. coli MRE600D.
- the adapted organism may have been transformed. It may have been transformed with the pJBDB02 vector (also known as pTrc99AtufA, the tufA gene encoding EFTu).
- the adapted organism may produce EFTu or a fragment, for example an immunogenic fragment, or a partially modified form thereof.
- Partial modification may for example be by way of addition, deletion or substitution of amino acid residues.
- a substitution may for example be a conserved substitution.
- a partially modified molecule may be a homologue ofthe molecule from which it was derived. It may for example have at least 40%, for example 50, 60, 70, 80, 90 or 95% homology with the molecule from which it is derived.
- the adapted organism may be E. coli MRE600DpJBDB02.
- Also provided according to the present invention are substances produced according to the method ofthe present invention.
- Bacterial elongation factor Tu is a 43 kDa protein which plays a crucial role in protein synthesis. It is the most extensively studied member of the G binding protein family, its role in bacteria being to deliver aminoacyl tRNA to the ribosome. EFTu binds a number of ligands including GTP, GDP, EFTs, aminoacyl tRNA, the ribosome, the antibiotics kirromycin and pulvomycin, and DNA. EFTu is too large for its interactions with these ligands to be studied satisfactorily with NMR using naturally abundant EFTu. However, deuteriated EFTu's interactions with these ligands may be readily studied, revealing hitherto unknown information about EFTu's interactions.
- MRE600 or a derivative thereof for use in the production of a substantially deuteriated substance.
- the MRE600 may be for use in a method according to any one ofthe preceding claims.
- substantially deuteriated EFTu having a substantially longer half-life in protiated media in the presence of chymotrypsin than protiated EFTu.
- substantially deuteriated EFTu has been prepared, allowing it to be studied with NMR.
- Figure 1 shows plasmid pJBDB02.
- Bases 1512-270 (the tufA EcoRI restriction site to the Smal restriction site) are derived from pTrc99A and the J226 bp tufA fragment was isolated from pJBDBOl by EcoRI digestion;
- Figure 2 shows SDS PAGE of crude cell lysate from MRE600DpJBDB02 cells grown on deuteriated succinate medium.
- Lanes 1 and 6 contain molecular weight markers of 14, 20, 30, 43, 67 and 94 kDa.
- Lane 2 contains a sample of crude cell lysate from a non- induced culture;
- lane 3 contains a sample of crude cell lysate from am IPTG-induced culture;
- lanes 4 and 5 contain 1 :10 dilutions of the lysate samples loaded into lanes 2 and 3 respectively.
- the strong band of EFTu at 43 kDa is clearly visible in samples from the induced culture and the high yield of EFTu in relation to other cell proteins is demonstrated;
- Figure 3 shows the degradation of perdeuteriated and protiated EFTu at 42 °C in H 2 0 (pH 8.0) and D 2 0 (pD 8.0);
- Figure 4 shows the degradation of perdeuteriated and protiated EFTu at 51 °C in D 2 0 (pD 8.0);
- Figure 5 shows the degradation by chymotrypsin of protiated and perdeuteriated EFTu in protiated media
- Figure 6 shows the degradation by chymotrypsin of protiated and perdeuteriated EFTu in deuteriated media.
- Bacteria were adapted to growth on deuteriated succinate medium and were transformed with a plasmid DNA vector. Resultant clones were screened for the presence ofthe vector and their ability to synthesise deuteriated EFTu.
- Results show that the method of the present invention has allowed the preparation of very high yields (nearly 100 mg/litre of culture medium) of deuteriated EFTu using a series of cultures containing d 4 -succinate/D 2 0 medium.
- the yields are equal to those obtained using natural abundance medium and the same clone.
- Deuteriated sodium succinate was prepared essentially as described by Stella, V.J., et al. (1973, J. Pharm. Sci., 62: 634) and LeMaster, D.M. and Richards, F.M. (1981, Analytical Biochemistry, 122: 238-247).
- Deuteriated sodium succinate medium was prepared as follows: 0.1 g NaOH, 2.4 g KH 2 P0 4 , 1.1 g deuteriated sodium succinate, 0.2 g (NH 4 ) 2 S0 4 , 30 mg FeS0 4 , 1 ⁇ l cone.
- H 2 S0 4 (Fissons) were slurried in 1 ml of 2 H 2 0 (D 2 0; Fluorochem) and stirred for 1 hour. The mixture was freeze dried and resuspended in 100 ml of 2 H 2 0 and filter sterilised.
- bacto agar For preparation of agar plates, 1.5 g bacto agar were added to 100 ml medium which was sterilised by autoclaving at 15 lb/sq.inch (approx. 10546 kg/ ⁇ r)for 20 minutes at 121 °C, in a sealed Duran bottle.
- E. C0/ MRE6OO National Collection of Industrial and Marine Bacteria
- was adapted to growth on deuteriated medium by growing successive liquid cultures in medium containing deuteriated sodium succinate as a carbon source in 70%, 80%, 90% and, finally, 100% 2 H 2 0.
- MRE600 adapted in this way are denoted MRE600D.
- the fragment was isolated from a low melting point agarose gel (BRL;
- E. coli MRE600D cells grown for a single generation on Luria's broth (LB) medium were made competent by treatment with calcium chloride and were transformed according to the method of Mandel, M. and Higa, A. (1970, J. Mol. Biol., 53_: 154-162). 10 ⁇ l of ligation products containing 100 ng of Trc99A DNA were added to 200 ⁇ l of competent cells and the suspension was incubated on ice for 1-3 hours before heat shocking at 42 °C for 2 minutes.
- LB medium was used in the transformation procedure, and transformants were placed on LB agar plates supplemented with 100 ⁇ g/ml ampicillin (Sigma). Following incubation overnight at 37°C, colonies were replica plated onto deuteriated succinate agar plates. Screening of MRE600DpJBDB02 clones
- the culture was grown at 37°C with shaking 250 rpm ( 3 /4 inch (1.9 cm) stroke). After approximately 40 hours incubation, when the optical density measured at 550 nm (OD 550 ) ofthe culture had reached 0.4, the culture was divided between two sterile 250 ml flasks. One ofthe cultures was induced by the addition of isopropylthiogalactoside (IPTG; NovaBiochem) to a final concentration of 1 mM, and incubation of both was continued as described. After a further 24 and 48 hours growth, two 1 ml samples were taken from each flask r and the cells isolated and lysed as described previously (Bloor and Barber, 1993, supra).
- IPTG isopropylthiogalactoside
- E. coli MRE600 which had not undergone adaptation to deuteriation could not be cultured in deuteriated medium.
- E. coli MRE600 which had undergone adaptation achieved a maximum OD 550 of 6.0 and cultures had a doubling time of approximately 6 hours.
- Plating deuterium adapted bacteria on deuteriated agar plates proved to be particularly important, resulting in improved growth rates and much reduced variability between cultures.
- Competent cells prepared from MRE600D cells grown for a single generation on protiated LB medium were successfully transformed with plasmid pBR322 when large quantities (100 ng) of DNA were used.
- MRE600D cells were also successfully transformed with plasmid pJBDB02 and, following transformation, it was possible to isolate transformants which had retained their ability to grow on deuteriated medium from replica deuteriated succinate agar plates. The feasibility of storing bacteria grown on deuteriated medium as frozen glycerol stocks has also been demonstrated.
- the yield of EFTu from deuteriated cultures ofthe MRE600DpJBDB02 clone was more than four times higher than that obtained from deuteriated cultures of MRE600pCP40pCI857 (Howard, T.D., 1991, PhD Thesis. University of Manchester, UK; Kennedy, K.K.. 1992, PhD Thesis, University of Manchester, UK).
- solutions of protiated or perdeuteriated EFTu were prepared at 0.5-0.6 mg ml "1 in 64.4 mM Tris buffer, pH 8 in H 2 0 or pD 8 in D 2 0.
- Samples of each ofthe four solutions protiated EFTu in H 2 O and D 2 0, perdeuteriated EFTu in H 2 0 and D 2 0 were allowed to denature at 8 °C, room temperature at 42 C C ( Figure 4).
- Protiated and perdeuteriated EFTu in D 2 0 were also degraded at 51 °C. All experiments were carried out in duplicate. Samples were removed at intervals and assayed for EFTu by the standard GDP exchange assay.
- D 2 0 has a stabilizing effect on both protiated and perdeuteriated EFTu at all the temperatures measured. For example at 42 °C the half life of normal EFTu is 70 minutes in H 2 O but 350 minutes in D 2 0. D 2 0 is known to affect the stability of proteins in aqueous solution. In many cases the effect is stabilizing, but destabilizing effects have also been reported.
- EFTu is an unstable protein which associates readily and which is stabilized in concentration solution. The destabilization of EFTu on perdeuteriation appears to arise from changes in hydrophobic interactions, including a decrease in association behaviour.
- t /2 represents the time after which one half of the protein has degraded. This is a true half life only at elevated temperatures.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9509052A JPH11511023A (en) | 1995-08-19 | 1996-08-14 | Deuterated substance |
EP96927785A EP0845038A1 (en) | 1995-08-19 | 1996-08-14 | Deuteriated substances |
AU67487/96A AU721877B2 (en) | 1995-08-19 | 1996-08-14 | Deuteriated substances |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9517026.2 | 1995-08-19 | ||
GB9517026A GB2304343A (en) | 1995-08-19 | 1995-08-19 | Deuterated product from culture in a deuterated medium |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997007216A1 true WO1997007216A1 (en) | 1997-02-27 |
Family
ID=10779491
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/GB1996/001988 WO1997007216A1 (en) | 1995-08-19 | 1996-08-14 | Deuteriated substances |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0845038A1 (en) |
JP (1) | JPH11511023A (en) |
AU (1) | AU721877B2 (en) |
CA (1) | CA2230051A1 (en) |
GB (1) | GB2304343A (en) |
WO (1) | WO1997007216A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003012048A2 (en) * | 2001-07-31 | 2003-02-13 | Board Of Regents, University Of Texas System | Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
WO2014078014A2 (en) | 2012-11-14 | 2014-05-22 | Metabolix, Inc. | Production of salts of 4-hydroxybutyrate using biobased raw materials |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0206691A2 (en) * | 1985-06-17 | 1986-12-30 | Nippon Paint Co., Ltd. | Production of deuterium-containing chemical substances |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH05246938A (en) * | 1992-02-19 | 1993-09-24 | Sagami Chem Res Center | Heavy hydrogen labeled higher fatty acid |
-
1995
- 1995-08-19 GB GB9517026A patent/GB2304343A/en not_active Withdrawn
-
1996
- 1996-08-14 CA CA 2230051 patent/CA2230051A1/en not_active Abandoned
- 1996-08-14 JP JP9509052A patent/JPH11511023A/en active Pending
- 1996-08-14 AU AU67487/96A patent/AU721877B2/en not_active Ceased
- 1996-08-14 WO PCT/GB1996/001988 patent/WO1997007216A1/en not_active Application Discontinuation
- 1996-08-14 EP EP96927785A patent/EP0845038A1/en not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0206691A2 (en) * | 1985-06-17 | 1986-12-30 | Nippon Paint Co., Ltd. | Production of deuterium-containing chemical substances |
Non-Patent Citations (2)
Title |
---|
KALBITZER H.R. ET AL.: "1H-NMR spectroscopy on elongation factor Tu from Escherichia coli", FEBS LETTERS, vol. 180, no. 1, 21 January 1985 (1985-01-21), pages 40 - 42, XP000611950 * |
KENNEDY K. ET AL.: "The molecular basis of the interaction of EF-Tu with kirromycin: overproduction of perdeuterated EF-Tu", BIOCHEMICAL SOCIETY TRANSACTIONS, vol. 19, no. 3, August 1991 (1991-08-01), pages 284s, XP000611936 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003012048A2 (en) * | 2001-07-31 | 2003-02-13 | Board Of Regents, University Of Texas System | Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
WO2003012048A3 (en) * | 2001-07-31 | 2004-01-15 | Univ Texas | Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
WO2014078014A2 (en) | 2012-11-14 | 2014-05-22 | Metabolix, Inc. | Production of salts of 4-hydroxybutyrate using biobased raw materials |
US11111202B2 (en) | 2012-11-14 | 2021-09-07 | Cj Cheiljedang Corporation | Production of salts of 4-hydroxybutyrate using biobased raw materials |
Also Published As
Publication number | Publication date |
---|---|
AU6748796A (en) | 1997-03-12 |
GB2304343A (en) | 1997-03-19 |
CA2230051A1 (en) | 1997-02-27 |
JPH11511023A (en) | 1999-09-28 |
AU721877B2 (en) | 2000-07-13 |
GB9517026D0 (en) | 1995-10-25 |
EP0845038A1 (en) | 1998-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Saint-Girons et al. | Methionine biosynthesis in enterobacteriaceae: Biochemical, regulatory, and evolutionary aspect | |
US7785832B2 (en) | Method of protein synthesis | |
FR2627508A1 (en) | METHOD FOR THE INTEGRATION OF A GENE CHOOSED ON CHROMOSOME OF A BACTERIUM AND BACTERIUM OBTAINED BY SAID METHOD | |
JPS6038114B2 (en) | Method for producing gene products from plasmid DNA | |
US8241887B2 (en) | High density growth of T7 expression strains with auto-induction option | |
CA2968491C (en) | Codon optimized polynucleotide for high level expression of crm197 | |
EP1412504B1 (en) | Methods of rna and protein synthesis | |
Hill et al. | Overexpression, purification, and characterization of Escherichia coli acyl carrier protein and 2 mutant proteins | |
CA2183632A1 (en) | Process for producing 2-keto-l-gulonic acid | |
AU721877B2 (en) | Deuteriated substances | |
US5786192A (en) | Farnesyl pyrophosphate synthetase and DNA sequence encoding the same | |
EP0233019A2 (en) | Recombinant DNA plasmid for xanthan gum synthesis | |
US4393135A (en) | Method for producing L-glutamic acid by fermentation | |
EP0469919A2 (en) | A process for the enzymatic preparation of 7-aminocephalosporanic acid | |
WO2004053111A1 (en) | Method of selecting escherichia coli strain overexpressing foreign gene, escherichia coli mutant thus selected and process for producing enzyme and compound using the same | |
EP0513806B1 (en) | Esterase genes, esterase, recombinant plasmids and transformants containing the recombinant plasmid and methods of producing optically active carboxylic acids and their enantiomeric esters using said transformants | |
US4504581A (en) | Method for producing L-histidine by fermentation | |
BRPI0719263A2 (en) | BETA-LACTAMA ANTIBIOTIC PRODUCTION | |
EP0240105B1 (en) | A gene coding for biotin synthetase and utilization thereof | |
US20060088925A1 (en) | Process for the intracellular over-production of streptokinase using genetically engineered strain of E.coli | |
Xiao | A Novel Epimerase Catalyzing Multiple Isomerization of Amino Acid Residues of Ribosomal Peptide | |
US5340732A (en) | Antiviral protein | |
US5766881A (en) | Induction-free process for the recombinant preparation of glutarylamidase | |
US20040191861A1 (en) | Method of protein synthesis | |
JPH0686681A (en) | Pha intracellular degrading enzyme |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG US UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 2230051 Country of ref document: CA Ref country code: CA Ref document number: 2230051 Kind code of ref document: A Format of ref document f/p: F Ref country code: JP Ref document number: 1997 509052 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996927785 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996927785 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996927785 Country of ref document: EP |